NewGenIvf (NIVF) Notes Payables (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Notes Payables of $256056.0 for Q4 2025, up 210.57% YoY from $82447.0 in Q4 2024, and up 210.57% sequentially from $82447.0 in Q4 2024.
NewGenIvf (NIVF) Notes Payables (2024 - 2025) Analysis & Trends
NewGenIvf has disclosed Notes Payables across 2 years of filings, most recently posting $256056.0 for Q4 2025.
- In Q4 2025, Notes Payables rose 210.57% year-over-year to $256056.0; the TTM figure through Dec 2025 stood at $256056.0 (up 210.57% YoY), while the FY2025 annual figure was $256056.0, up 210.57% from the prior year.
- Notes Payables grew to $256056.0 in Q4 2025, from $82447.0 in the prior quarter.
- Over the last five years, Notes Payables for NIVF reached as high as $256056.0 in Q4 2025 and fell as low as $82447.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn |
| 10 | NewGenIvf | 25,304.95 | -1.41 Mn | 524,025.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 256,056.00 |
| Dec 31, 2024 | 82,447.00 |